GeneFerm Biotechnology Co

GeneFerm Biotechnology Co Net Margin

The Net Profit Margin of GeneFerm Biotechnology Co (1796.TWO) as of Oct 16, 2026 is 4.26 %. In the previous year, Net Profit Margin was -4.32 % — a change of -198.61% (higher).

Net Margin

4.26 %

YoY

-198.61%

Last updated:

Net Profit Margin of GeneFerm Biotechnology Co is 2025 4.26 % . Net Profit Margin of GeneFerm Biotechnology Co was 2024 -4.32 % . It decreases by -198.61% higher compared to the previous year.

For GeneFerm Biotechnology Co, the net margin of 4.3% is down versus 11.0% a few years ago.

The GeneFerm Biotechnology Co Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
2.89 TWD
Jan 1, 2019
-8.39 TWD
Jan 1, 2020
1.23 TWD
Jan 1, 2021
10.99 TWD
Jan 1, 2022
14.74 TWD
Jan 1, 2023
15.70 TWD
Jan 1, 2024
-4.32 TWD
Jan 1, 2025
4.26 TWD
The GeneFerm Biotechnology Co Net Margin history
YEARNet MarginYoY
4.26 %-198.61%
-4.32 %-127.53%
15.70 %+6.50%
14.74 %+34.11%
10.99 %+793.85%
1.23 %-114.65%
-8.39 %-390.86%
2.89 %-64.24%
8.07 %-61.20%
20.80 %+43.62%
14.48 %-274.67%
-8.29 %-30,941.38%
0.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

Net Profit Margin of GeneFerm Biotechnology Co is 4.26 % in 2025.

Net Profit Margin of GeneFerm Biotechnology Co changed from -4.32 % to 4.26 %, representing a -198.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's GeneFerm Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — GeneFerm Biotechnology Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — GeneFerm Biotechnology Co